JP2002543769A5 - - Google Patents

Download PDF

Info

Publication number
JP2002543769A5
JP2002543769A5 JP2000611554A JP2000611554A JP2002543769A5 JP 2002543769 A5 JP2002543769 A5 JP 2002543769A5 JP 2000611554 A JP2000611554 A JP 2000611554A JP 2000611554 A JP2000611554 A JP 2000611554A JP 2002543769 A5 JP2002543769 A5 JP 2002543769A5
Authority
JP
Japan
Prior art keywords
polynucleotide
patient
polypeptide
cancer
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000611554A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002543769A (ja
Filing date
Publication date
Priority claimed from US09/285,479 external-priority patent/US6821518B1/en
Priority claimed from US09/466,396 external-priority patent/US6696247B2/en
Priority claimed from US09/476,496 external-priority patent/US6706262B1/en
Priority claimed from US09/480,884 external-priority patent/US6482597B1/en
Application filed filed Critical
Priority claimed from PCT/US2000/008896 external-priority patent/WO2000061612A2/en
Publication of JP2002543769A publication Critical patent/JP2002543769A/ja
Publication of JP2002543769A5 publication Critical patent/JP2002543769A5/ja
Pending legal-status Critical Current

Links

JP2000611554A 1999-04-02 2000-04-03 肺癌の治療および診断のための化合物および方法 Pending JP2002543769A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US09/285,479 US6821518B1 (en) 1998-03-18 1999-04-02 Compounds and methods for therapy and diagnosis of lung cancer
US09/285,479 1999-04-02
US09/466,396 US6696247B2 (en) 1998-03-18 1999-12-17 Compounds and methods for therapy and diagnosis of lung cancer
US09/466,396 1999-12-17
US09/476,496 US6706262B1 (en) 1998-03-18 1999-12-30 Compounds and methods for therapy and diagnosis of lung cancer
US09/476,496 1999-12-30
US09/480,884 US6482597B1 (en) 1999-12-17 2000-01-10 Compounds and methods for therapy and diagnosis of lung cancer
US09/480,884 2000-01-10
US51037600A 2000-02-22 2000-02-22
US09/510,376 2000-02-22
PCT/US2000/008896 WO2000061612A2 (en) 1999-04-02 2000-04-03 Compounds and methods for therapy and diagnosis of lung cancer

Publications (2)

Publication Number Publication Date
JP2002543769A JP2002543769A (ja) 2002-12-24
JP2002543769A5 true JP2002543769A5 (enExample) 2007-06-07

Family

ID=27540689

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000611554A Pending JP2002543769A (ja) 1999-04-02 2000-04-03 肺癌の治療および診断のための化合物および方法

Country Status (20)

Country Link
EP (2) EP1169347B1 (enExample)
JP (1) JP2002543769A (enExample)
KR (1) KR20020007354A (enExample)
CN (1) CN1370182A (enExample)
AT (1) ATE399793T1 (enExample)
AU (1) AU4069200A (enExample)
BR (1) BR0009505A (enExample)
CA (1) CA2369578A1 (enExample)
CZ (1) CZ20013527A3 (enExample)
DE (1) DE60039353D1 (enExample)
EA (1) EA005140B1 (enExample)
ES (1) ES2308976T3 (enExample)
HK (1) HK1049848A1 (enExample)
HU (1) HUP0200760A2 (enExample)
IL (1) IL145731A0 (enExample)
MX (1) MXPA01009962A (enExample)
NZ (1) NZ514818A (enExample)
PL (1) PL354348A1 (enExample)
WO (1) WO2000061612A2 (enExample)
YU (1) YU72901A (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338937B2 (en) * 1997-11-17 2008-03-04 Cornell Research Foundation, Inc. Calcium-activated chloride channel proteins and their use in anti-metastatic therapy
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20040235072A1 (en) * 1998-03-18 2004-11-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US6737514B1 (en) 1998-12-22 2004-05-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20020147143A1 (en) * 1998-03-18 2002-10-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US20030236209A1 (en) * 1998-03-18 2003-12-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
CA2383358A1 (en) * 1999-08-31 2001-03-08 Board Of Regents, The University Of Texas System Methods and compositions of a novel serine protease inhibitor
CA3016482A1 (en) 1999-11-30 2001-06-07 Mayo Foundation For Medical Education And Research B7-h1, a novel immunoregulatory molecule
US7030219B2 (en) 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
US7108977B2 (en) * 2000-05-19 2006-09-19 Hoffmann-La Roche Inc. Process for determining the tumoricidal potential of a sample the use of a nucleic acid which is downregulated in human tumor cells
AU6531101A (en) 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6965018B2 (en) 2000-06-06 2005-11-15 Bristol-Myers Squibb Company Antibodies directed to B7-related polypeptide, BSL-2
US20030031675A1 (en) 2000-06-06 2003-02-13 Mikesell Glen E. B7-related nucleic acids and polypeptides useful for immunomodulation
WO2002000692A2 (en) * 2000-06-28 2002-01-03 Genetics Institute, Llc. Pd-l2 molecules: pd-1 ligands and uses therefor
EP1319069B1 (en) * 2000-06-28 2008-05-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6635750B1 (en) 2000-07-20 2003-10-21 Millennium Pharmaceuticals, Inc. B7-H2 nucleic acids, members of the B7 family
AU2001280987A1 (en) * 2000-08-03 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of head and neck cancer
AU2006202524B2 (en) * 2000-09-20 2009-12-03 Amgen, Inc. B7-Like Molecules and Uses Thereof
CA2422215A1 (en) 2000-09-20 2002-03-28 Amgen Inc. B7-like molecules and uses thereof
CA2431861A1 (en) 2000-12-08 2002-06-13 Curagen Corporation Method of detecting and treating tuberous sclerosis complex associated disorders
EP2161578A1 (en) * 2001-05-29 2010-03-10 Pride Proteomics A/S Proteins in diabetes proteome analysis
EP1428882A4 (en) 2001-08-24 2005-05-25 Hisamitsu Pharmaceutical Co DIFFERENT EXPRESSION IN HEPATOBLASTOM AND NORMAL LIVER DISPLAYING NUCLEIC ACIDS
WO2004002516A1 (ja) * 2002-06-28 2004-01-08 Takeda Chemical Industries, Ltd. 呼吸器疾患の診断・予防・治療剤
WO2004016636A1 (en) * 2002-08-14 2004-02-26 Lg Life Sciences Ltd. Gene families associated with stomach cancer
US7378495B2 (en) 2002-10-21 2008-05-27 Pevion Biotech, Ltd. PTH-rP related peptide cancer therapeutics
EP1469064A1 (en) * 2003-04-15 2004-10-20 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Expression of proteins in endothelial cells derived from precursor cells from cord blood
PL1810026T3 (pl) 2004-10-06 2018-08-31 Mayo Foundation For Medical Education And Research B7-H1 i PD-1 w leczeniu raka nerkowokomórkowego
WO2006105642A1 (en) * 2005-04-05 2006-10-12 British Columbia Cancer Agency Biomarkers for the detection of lung cancer and uses thereof
DK1907000T4 (da) 2005-06-08 2020-03-30 The President And Fellows Of Harvard College Fremgangsmåder og sammensætninger til behandling af persisterende HIV-infektioner ved hæmning af reaktionsvejen for programmeret celledød 1 (PD-1).
RU2481398C2 (ru) * 2006-12-28 2013-05-10 Интернешнл Инститьют Оф Кэнсер Иммунолоджи, Инк. Hla-a*1101-ограниченный пептид wt1 и содержащая его фармацевтическая композиция
KR100873629B1 (ko) * 2007-01-05 2008-12-12 경북대학교 산학협력단 신규한 폐암 진단용 마커
MX2011005691A (es) 2008-11-28 2011-07-20 Univ Emory Metodos para el tratamiento de infecciones y tumores.
US11261494B2 (en) 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
US9302005B2 (en) 2013-03-14 2016-04-05 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
EP3470081A1 (en) 2013-10-01 2019-04-17 Mayo Foundation for Medical Education and Research Methods for treating cancer in patients with elevated levels of bim
AU2014375224A1 (en) * 2014-01-05 2016-07-28 Biomirna Holdings Ltd Lung cancer determinations using miRNA ratios
US10302653B2 (en) 2014-05-22 2019-05-28 Mayo Foundation For Medical Education And Research Distinguishing antagonistic and agonistic anti B7-H1 antibodies
US10517875B2 (en) 2014-07-23 2019-12-31 Mayo Foundation for Medical Engineering and Research Targeting DNA-PKcs and B7-H1 to treat cancer
DK3256605T3 (da) 2015-02-10 2022-03-14 Univ Hong Kong Chinese Påvisning af mutationer til cancerscreening og føtal analyse
US10453556B2 (en) 2015-07-23 2019-10-22 The Chinese University Of Hong Kong Analysis of fragmentation patterns of cell-free DNA
WO2017075045A2 (en) 2015-10-30 2017-05-04 Mayo Foundation For Medical Education And Research Antibodies to b7-h1
WO2018137685A1 (en) 2017-01-25 2018-08-02 The Chinese University Of Hong Kong Diagnostic applications using nucleic acid fragments
WO2019020057A1 (en) 2017-07-26 2019-01-31 The Chinese University Of Hong Kong ENHANCING CANCER SCREENING WITH ACELLULAR VIRAL NUCLEIC ACIDS
US12624086B2 (en) 2018-10-31 2026-05-12 Mayo Foundation For Medical Education And Research Materials and methods for treating cancer
US12257286B2 (en) 2018-10-31 2025-03-25 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
US12264189B2 (en) 2018-10-31 2025-04-01 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
US4489710A (en) 1981-06-23 1984-12-25 Xoma Corporation Composition and method for transplantation therapy
US4429008B1 (en) 1981-12-10 1995-05-16 Univ California Thiol reactive liposomes
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4769330A (en) 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
US4671958A (en) 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
US4436727A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4866034A (en) 1982-05-26 1989-09-12 Ribi Immunochem Research Inc. Refined detoxified endotoxin
JPS59116229A (ja) 1982-12-24 1984-07-05 Teijin Ltd 細胞毒性複合体を活性成分とする癌治療用剤およびその製造法
US4673562A (en) 1983-08-19 1987-06-16 The Children's Medical Center Corporation Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents
US4873088A (en) 1983-09-06 1989-10-10 Liposome Technology, Inc. Liposome drug delivery method and composition
US4625014A (en) 1984-07-10 1986-11-25 Dana-Farber Cancer Institute, Inc. Cell-delivery agent
US4542225A (en) 1984-08-29 1985-09-17 Dana-Farber Cancer Institute, Inc. Acid-cleavable compound
US4918164A (en) 1987-09-10 1990-04-17 Oncogen Tumor immunotherapy using anti-idiotypic antibodies
US4638045A (en) 1985-02-19 1987-01-20 Massachusetts Institute Of Technology Non-peptide polyamino acid bioerodible polymers
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
GB8508845D0 (en) 1985-04-04 1985-05-09 Hoffmann La Roche Vaccinia dna
US4777127A (en) 1985-09-30 1988-10-11 Labsystems Oy Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US4699784A (en) 1986-02-25 1987-10-13 Center For Molecular Medicine & Immunology Tumoricidal methotrexate-antibody conjugate
US4877611A (en) 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
GB8702816D0 (en) 1987-02-07 1987-03-11 Al Sumidaie A M K Obtaining retrovirus-containing fraction
US4735792A (en) 1987-04-28 1988-04-05 The United States Of America As Represented By The United States Department Of Energy Radioiodinated maleimides and use as agents for radiolabeling antibodies
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
WO1989001973A2 (en) 1987-09-02 1989-03-09 Applied Biotechnology, Inc. Recombinant pox virus for immunization against tumor-associated antigens
WO1989006280A1 (en) 1988-01-04 1989-07-13 E.I. Du Pont De Nemours And Company Multiple stage affinity process for isolation of specific cells from a cell mixture
US5215926A (en) 1988-06-03 1993-06-01 Cellpro, Inc. Procedure for designing efficient affinity cell separation processes
AP129A (en) 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
EP1001032A3 (en) 1989-08-18 2005-02-23 Chiron Corporation Recombinant retroviruses delivering vector constructs to target cells
KR920007887B1 (ko) 1989-08-29 1992-09-18 스즈키 지도오샤 고오교오 가부시키가이샤 내연기관의 배기가스 정화장치
WO1991016116A1 (en) 1990-04-23 1991-10-31 Cellpro Incorporated Immunoselection device and method
SE466259B (sv) 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
DK0553288T3 (da) 1990-10-18 1997-12-29 Cellpro Inc Apparat og fremgangsmåde til udskillelse af partikler ved brug af en eftergivende beholder
US5240856A (en) 1991-10-23 1993-08-31 Cellpro Incorporated Apparatus for cell separation
DE69313134T2 (de) 1992-06-25 1998-02-26 Smithkline Beecham Biolog Adjuvantien enthaltende impfstoffzusammensetzung
CA2144750A1 (en) * 1992-09-17 1994-03-31 Rolf Stahel Tumor-specific antibodies and antigen
US5359681A (en) 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
FR2702160B1 (fr) 1993-03-02 1995-06-02 Biovecteurs As Vecteurs particulaires synthétiques et procédé de préparation.
FR2704145B1 (fr) 1993-04-21 1995-07-21 Pasteur Institut Vecteur particulaire et composition pharmaceutique le contenant.
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US5550214A (en) * 1994-02-10 1996-08-27 Brigham And Women's Hospital Isolated antigenic oncogene peptide fragments and uses
AU713040B2 (en) 1994-07-15 1999-11-18 University Of Iowa Research Foundation, The Immunomodulatory oligonucleotides
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
EP0695760A1 (en) * 1994-08-05 1996-02-07 F. Hoffmann-La Roche Ag Novel tumor marker for lung cancer
FR2723849B1 (fr) 1994-08-31 1997-04-11 Biovector Therapeutics Sa Procede pour augmenter l'immunogenicite, produit obtenu et composition pharmaceutique
US5744585A (en) * 1995-03-16 1998-04-28 Medenica; Rajko D. Human monoclonal antibody against lung carcinoma
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
EP0832282A1 (en) 1995-06-02 1998-04-01 Incyte Pharmaceuticals, Inc. IMPROVED METHOD FOR OBTAINING FULL-LENGTH cDNA SEQUENCES
AU6643596A (en) * 1995-08-11 1997-03-12 United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The Isolation of amplified genes via cdna subtractive hybridization
EP0871747A1 (en) 1996-01-02 1998-10-21 Chiron Viagene, Inc. Immunostimulation mediated by gene-modified dendritic cells
ES2284200T3 (es) * 1997-02-12 2007-11-01 Electrophoretics Limited Marcadores proteicos para cancer de pulmon y uso de los mismos.
EP0972084A2 (en) * 1997-04-11 2000-01-19 Micromet Gesellschaft für Biomedizinische Forschung mbH Primers and methods for the detection of disseminated tumor cells
CA2292788A1 (en) * 1997-06-11 1998-12-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
GB9727262D0 (en) 1997-12-24 1998-02-25 Smithkline Beecham Biolog Vaccine
ID27813A (id) * 1998-01-28 2001-04-26 Corixa Corp Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
AU3094999A (en) * 1998-03-18 1999-10-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6312695B1 (en) 1998-03-18 2001-11-06 Corixa Corporation Compounds and methods for therapy of lung cancer
US6297364B1 (en) * 1998-04-17 2001-10-02 Ludwig Institute For Cancer Research Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof

Similar Documents

Publication Publication Date Title
JP2006515749A5 (enExample)
JP2002532093A5 (enExample)
JP2005504513A5 (enExample)
CA2142575A1 (en) Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
WO1999049083A9 (en) Diagnosis of disease state using mrna profiles in peripheral leukocytes
WO2001021810B1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
JP2002543769A (ja) 肺癌の治療および診断のための化合物および方法
JP4270523B2 (ja) 乳癌の処置および診断のための組成物および方法
IE891945L (en) Cdnas coding for members of the carcinoembryonic antigen¹family
JP2005097311A (ja) 抗原
JP2009039107A5 (enExample)
JP2006518186A5 (enExample)
JP2001526035A5 (enExample)
JP2001521744A5 (enExample)
WO2021067550A1 (en) Methods and compositions for identifying neoantigens for use in treating and preventing cancer
JP2002512005A5 (enExample)
RU96102857A (ru) Последовательность днк, кодирующая для белка, а.талианы, обладающего дельта-5,7 стерин, дельта-7 редуктазной активностью, белка дельта-7 ред, метод их получения, трансформированные дрожжевые штаммы, виды применения.
US6713617B2 (en) Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
CN105940115B (zh) 恶性疟原虫青蒿素耐药性的分子标记物
US9011878B2 (en) Vaccine strains of Brachyspira hyodysenteriae
FR2771751A1 (fr) Erythrovirus et ses applications
JP2004512021A (ja) ミクロサテライト不安定（ｍｓｉ＋）腫瘍に適切な遺伝子およびその遺伝子産物
US7666586B2 (en) Gene expression in biological conditions
CA2365196A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
JP2003533990A5 (enExample)